Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;19(3):194-206.
doi: 10.1007/s11904-022-00604-2. Epub 2022 Apr 11.

HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies

Affiliations
Review

HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies

Edward F Kreider et al. Curr HIV/AIDS Rep. 2022 Jun.

Abstract

Purpose of review: Despite suppressive antiretroviral therapy (ART), a viral reservoir persists in individuals living with HIV that can reignite systemic replication should treatment be interrupted. Understanding how HIV-1 persists through effective ART is essential to develop cure strategies to induce ART-free virus remission.

Recent findings: The HIV-1 reservoir resides in a pool of CD4-expressing cells as a range of viral species, a subset of which is genetically intact. Recent studies suggest that the reservoir on ART is highly dynamic, with expansion and contraction of virus-infected cells over time. Overall, the intact proviral reservoir declines faster than defective viruses, suggesting enhanced immune clearance or cellular turnover. Upon treatment interruption, rebound viruses demonstrate escape from adaptive and innate immune responses, implicating these selective pressures in restriction of virus reactivation. Cure strategies employing immunotherapy are poised to test whether host immune pressure can be augmented to enhance reservoir suppression or clearance. Alternatively, genomic engineering approaches are being applied to directly eliminate intact viruses and shrink the replication-competent virus pool. New evidence suggests host immunity exerts selective pressure on reservoir viruses and clears HIV-1 infected cells over years on ART. Efforts to build on the detectable, but insufficient, reservoir clearance via empiric testing in clinical trials will inform our understanding of mechanisms of viral persistence and the direction of future cure strategies.

Keywords: Cure; HIV-1 reservoirs; Persistence; Viral rebound.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Dynamics of the HIV-1 reservoir following ART initiation. A Schematization of three measures of the proviral reservoir size plotted over time. “Total proviral DNA” corresponds to quantitative measurements of any proviral genomes, which are generally stable overtime. Methods that can differentiate defective from intact proviruses like IPDA and Q4PCR have shown relative stability of rthe defective pool, but a gradual decline in the intact proviral reservoir (red line). B Multiple forces that impact the size of the intact (filled color circles) and defective (white circles) proviral reservoir have been identified and/or postulated. Forces that expand population size are listed on top and forces thought to cause decay of the intact reservoir shown on bottom. C With time on suppressive ART, cells harboring intact proviral populations decrease in total number and become more clonal, as indicated by the expansion of certain clones (e.g., red clone) and loss of others (e.g., yellow clone). Figure created with BioRender

References

    1. Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000–2016. Jama Netw Open. 2020;3:e207954. - PMC - PubMed
    1. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013;27:973–9. - PubMed
    1. Salantes DB, Zheng Y, Mampe F, Srivastava T, Beg S, Lai J, et al. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest. 2018;128:3102–15. - PMC - PubMed
    1. Li JZ, Etemad B, Ahmed H, Aga E, Bosch RJ, Mellors JW, et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 2016;30:343–53. - PMC - PubMed
    1. Wood BR, Huhn GD. Excess weight gain with integrase inhibitors and tenofovir alafenamide: what is the mechanism and does it matter? Open Forum Infect Dis. 2021;8:ofab542. - PMC - PubMed

Publication types

Substances